"Monophenol Monooxygenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.
| Descriptor ID |
D014442
|
| MeSH Number(s) |
D08.811.682.690.708.125.500
|
| Concept/Terms |
Monophenol Monooxygenase- Monophenol Monooxygenase
- Monooxygenase, Monophenol
- Dopa Oxidase
- Oxidase, Dopa
- Phenol Oxidase
- Oxidase, Phenol
- Phenoloxidase
- Tyrosinase
- Cresolase
|
Below are MeSH descriptors whose meaning is more general than "Monophenol Monooxygenase".
Below are MeSH descriptors whose meaning is more specific than "Monophenol Monooxygenase".
This graph shows the total number of publications written about "Monophenol Monooxygenase" by people in this website by year, and whether "Monophenol Monooxygenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Monophenol Monooxygenase" by people in Profiles.
-
Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses. Proc Natl Acad Sci U S A. 2010 Aug 10; 107(32):14286-91.
-
An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy. Int J Oncol. 2007 Nov; 31(5):1177-85.
-
B cell antigen receptor signaling and internalization are mutually exclusive events. PLoS Biol. 2006 Jul; 4(7):e200.
-
Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol. 2006 Sep; 19(9):1255-60.
-
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo. Cancer Res. 2005 Mar 01; 65(5):2009-17.
-
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res. 2005 Feb 15; 65(4):1570-6.
-
Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol. 2001 Sep; 28(8):400-6.
-
A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component. Gene Ther. 2001 Jul; 8(13):987-98.
-
Malignant melanoma with paradoxical maturation. Am J Surg Pathol. 2000 Dec; 24(12):1600-14.
-
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med. 1999 Jun; 5(6):677-85.